C. Romero-Gómez

Patient with Systemic Lupus Erythematosus who Presented with Area Postrema Syndrome after COVID-19 Vaccination

R. Gómez-Huelgas, C. Romero-Gómez, Pablo López-Quirantes, 2022, American Journal of Medical Case Reports.

Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

S. García-Morillo, J. C. Callejas Rubio, E. de Miguel, 2021, Therapeutic advances in musculoskeletal disease.

nosed. In southern Spain, the incidence and prevalence of PSV are lower than in northern Spain and in countries in the Northern Hemisphere

J. Hernández-Rodríguez, C. Romero-Gómez, J. Olalla-Sierra, 2015 .

Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.

J. Hernández-Rodríguez, C. Romero-Gómez, J. Olalla-Sierra, 2015, Clinical and experimental rheumatology.

Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps—A Rapid Scoping Review

M. Bernal-López, R. Gómez-Huelgas, C. Romero-Gómez, 2022, International journal of environmental research and public health.

Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab

R. Fúnez-Liébana, C. Romero-Gómez, I. Fernández-Canedo, 2021, Rheumatology International.

Neurotoxicity induced by metronidazole.

C. Romero-Gómez, J. Aparicio-Camberos, J. Aguilar-García, 2019, Neurología.